Novo Nordisk reported 482.15B in Assets for its fiscal quarter ending in June of 2025.


Assets Change Date
Bausch Health Companies USD 27.27B 845M Jun/2025
Bristol-Myers Squibb USD 94.68B 2.25B Jun/2025
Eli Lilly USD 100.92B 11.53B Jun/2025
GlaxoSmithKline GBP 59.26B 1.45B Jun/2025
Merck USD 117.52B 2.4B Jun/2025
Novartis USD 104.4B 4.45B Jun/2025
Novo Nordisk 482.15B 7.01B Jun/2025
Novo Nordisk DKK 489.16B 91.72B Mar/2025
Pacira USD 1.54B 49.41M Jun/2025
Sanofi 124.96B 6.93B Jun/2025
Supernus Pharmaceuticals USD 1.38B 35.11M Jun/2025